Executive Director, Global Clinical Supply Chain - Oncology at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceuticals, OncologyIndustries

Requirements

Expertise in clinical planning within oncology therapeutic area
Knowledge of diverse portfolio including small molecules, biologics, and cell/gene therapy for global clinical trials
Experience leading end-to-end clinical supply chain from protocol design through manufacturing, distribution, and inventory management
Ability to work cross-functionally with Development Operations, Clinical Operations, Process Development and Manufacturing (PDM), and other enterprise functions
Leadership skills to inspire, motivate, and manage teams, including recruitment, onboarding, and succession planning
Capability to lead large complex projects and represent GCSC in cross-functional initiatives

Responsibilities

Lead clinical planning function within assigned therapeutic area (TA) as an end-to-end leader, inspiring and motivating teams while developing overall strategy for GCSC
Provide subject matter expertise on development programs and therapeutic modalities
Establish strategies to ensure uninterrupted clinical supply for development portfolio, including all phases of clinical programs and managed access programs
Lead, develop, and manage team, including recruitment, onboarding, and succession planning
Drive excellence, set clear goals aligned with department and enterprise objectives, and ensure consistent delivery
Develop and maintain a culture of continuous improvement, mobilizing teams to identify and implement best practices cross-functionally with PDM and enterprise
Perform sponsor roles as requested
Champion clinical demand and operation planning (CD&OP), interfacing with Clinical Operations and PDM sub-teams
Manage across enterprise functions and partners to ensure on-time, in-full delivery of investigational medicinal product (IMP)
Ensure efficient and robust resource allocation for PDM sub-teams and clinical study teams
Partner across PDM functions and other enterprise areas

Skills

Supply Chain Management

Clinical Supply Planning

Therapeutic Area Strategy

Team Leadership

Global Operations

Biopharmaceuticals

Oncology

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free